{"id":"https://openalex.org/W2168598587","doi":null,"title":"Polypharmacy in the psychiatric treatment of elderly hospitalized patients: a survey of 12 Veterans Administration Hospitals.","display_name":"Polypharmacy in the psychiatric treatment of elderly hospitalized patients: a survey of 12 Veterans Administration Hospitals.","publication_year":1976,"publication_date":"1976-06-01","ids":{"openalex":"https://openalex.org/W2168598587","mag":"2168598587","pmid":"https://pubmed.ncbi.nlm.nih.gov/6221"},"language":"en","primary_location":{"id":"pmid:6221","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/6221","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diseases of the nervous system","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5048405330","display_name":"Prein Rf","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R F Prein","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079672891","display_name":"C. James Klett","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C J Klett","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5038108665","display_name":"Eugene M. Caffey","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E M Caffey","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":17,"citation_normalized_percentile":{"value":0.1553288,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"37","issue":"6","first_page":"333","last_page":"6"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10496","display_name":"Pharmaceutical Practices and Patient Outcomes","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2717","display_name":"Geriatrics and Gerontology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10496","display_name":"Pharmaceutical Practices and Patient Outcomes","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2717","display_name":"Geriatrics and Gerontology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10272","display_name":"Mental Health Treatment and Access","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13944","display_name":"Psychiatric care and mental health services","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/polypharmacy","display_name":"polypharmacy","score":1.0},{"id":"https://openalex.org/keywords/psychoactive-substances","display_name":"psychoactive substances","score":0.8429999947547913},{"id":"https://openalex.org/keywords/elderly-psychiatric-patients","display_name":"elderly psychiatric patients","score":0.9089999794960022},{"id":"https://openalex.org/keywords/hospitalized-older-adults","display_name":"hospitalized older adults","score":0.6919999718666077},{"id":"https://openalex.org/keywords/antipsychotic-drugs","display_name":"antipsychotic drugs","score":0.7879999876022339},{"id":"https://openalex.org/keywords/thioridazine","display_name":"thioridazine","score":0.9390000104904175},{"id":"https://openalex.org/keywords/chlorpromazine","display_name":"chlorpromazine","score":0.9900000095367432},{"id":"https://openalex.org/keywords/phenobarbital","display_name":"phenobarbital","score":0.9660000205039978},{"id":"https://openalex.org/keywords/antidepressants","display_name":"antidepressants","score":0.9629999995231628},{"id":"https://openalex.org/keywords/anxiolytics","display_name":"anxiolytics","score":0.8149999976158142},{"id":"https://openalex.org/keywords/sedative-hypnotics","display_name":"sedative-hypnotic drugs","score":0.949999988079071},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.8569999933242798},{"id":"https://openalex.org/keywords/veterans-affairs-hospitals","display_name":"Veterans Affairs hospitals","score":0.8479999899864197}],"concepts":[{"id":"https://openalex.org/C36434225","wikidata":"https://www.wikidata.org/wiki/Q1895998","display_name":"Polypharmacy","level":2,"score":0.9217817783355713},{"id":"https://openalex.org/C2780688371","wikidata":"https://www.wikidata.org/wiki/Q58375","display_name":"Thioridazine","level":3,"score":0.7739317417144775},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.772804856300354},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.7426855564117432},{"id":"https://openalex.org/C2778775820","wikidata":"https://www.wikidata.org/wiki/Q407972","display_name":"Chlorpromazine","level":2,"score":0.6480126976966858},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.5099691152572632},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.4743700623512268},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4581751525402069},{"id":"https://openalex.org/C2780930544","wikidata":"https://www.wikidata.org/wiki/Q62962","display_name":"Hypnotic","level":2,"score":0.44098007678985596},{"id":"https://openalex.org/C2779369099","wikidata":"https://www.wikidata.org/wiki/Q3706669","display_name":"Psychoactive drug","level":3,"score":0.43730059266090393},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.2606726288795471},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.245533287525177},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000367","descriptor_name":"Age Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D001523","descriptor_name":"Mental Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002746","descriptor_name":"Chlorpromazine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004088","descriptor_name":"Dihydroergotoxine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004359","descriptor_name":"Drug Therapy, Combination","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006993","descriptor_name":"Hypnotics and Sedatives","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010634","descriptor_name":"Phenobarbital","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011619","descriptor_name":"Psychotropic Drugs","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D013881","descriptor_name":"Thioridazine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014151","descriptor_name":"Anti-Anxiety Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014493","descriptor_name":"United States Department of Veterans Affairs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019965","descriptor_name":"Neurocognitive Disorders","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:6221","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/6221","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diseases of the nervous system","raw_type":"Journal Article"},{"id":"mag:2168598587","doi":null,"is_oa":false,"landing_page_url":"https://europepmc.org/article/MED/6221","pdf_url":null,"source":{"id":"https://openalex.org/S2755941412","display_name":"Diseases of the nervous system","issn_l":"0012-3714","issn":["0012-3714"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Diseases of the nervous system","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[{"id":"https://openalex.org/study-designs/observational-study","display_name":"Observational Study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2066393039","https://openalex.org/W2006289687","https://openalex.org/W2398524523","https://openalex.org/W7204558248","https://openalex.org/W6941057293","https://openalex.org/W4400662696","https://openalex.org/W3082493689","https://openalex.org/W2051702024","https://openalex.org/W2409252386","https://openalex.org/W7096777274"],"abstract_inverted_index":{"Polypharmacy":[0],"with":[1],"psychoactive":[2,26,131],"drugs":[3,32,132],"was":[4,33,72,109],"surveyed":[5],"in":[6],"1276":[7],"elderly":[8],"psychiatric":[9],"patients":[10,21,53,120],"from":[11],"12":[12],"Veterans":[13],"Administration":[14],"hospitals.":[15],"One":[16,68,115],"out":[17,116,137],"of":[18,31,56,62,75,78,107,117,125,138,143,147],"every":[19,118],"six":[20],"received":[22,127],"two":[23,92,128],"or":[24,103,129],"more":[25,130],"agents.":[27,67],"No":[28],"specific":[29],"combination":[30],"overly":[34],"popular.":[35],"The":[36,59,81,105,145],"most":[37,82],"frequently":[38],"administered":[39,49],"combinations,":[40],"thioridazine":[41],"plus":[42,46,89,99],"phenobarbital":[43],"and":[44,90,95,152],"chlorpromazine":[45],"phenobarbital,":[47],"were":[48,85],"to":[50,112,122,134],"only":[51,135],"13":[52],"each":[54],"(1%":[55],"the":[57,63,79],"sample).":[58],"large":[60],"majority":[61],"combinations":[64],"involved":[65],"antipsychotic":[66,69,87,93,97],"drug,":[70],"thioridazine,":[71],"a":[73],"component":[74],"nearly":[76],"one-third":[77],"combinations.":[80],"frequent":[83],"pairings":[84],"an":[86,96,100],"drug":[88,98],"antidepressant,":[91],"drugs,":[94],"antianxiety":[101],"agent":[102],"sedative-hypnotic.":[104],"use":[106],"polypharmacy":[108],"significantly":[110],"related":[111],"patient":[113],"age.":[114,144],"four":[119],"60":[121],"65":[123],"years":[124,142],"age":[126],"compared":[133],"one":[136],"eight":[139],"over":[140],"75":[141],"implications":[146],"these":[148],"findings":[149],"for":[150],"treatment":[151],"research":[153],"are":[154],"discussed.":[155]},"counts_by_year":[],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}